Aspen Aerogels, Inc.

NYSE:ASPN Rapport sur les actions

Capitalisation boursière : US$1.2b

Aspen Aerogels Croissance future

Future contrôle des critères 5/6

Aspen Aerogels devrait augmenter ses bénéfices et son chiffre d'affaires de 54.4% et de 22.9% par an respectivement. Le BPA devrait croître de de 53.6% par an. Le rendement des capitaux propres devrait être 10.1% dans 3 ans.

Informations clés

54.4%

Taux de croissance des bénéfices

53.6%

Taux de croissance du BPA

Chemicals croissance des bénéfices17.0%
Taux de croissance des recettes22.9%
Rendement futur des capitaux propres10.1%
Couverture par les analystes

Good

Dernière mise à jour12 Nov 2024

Mises à jour récentes de la croissance future

Recent updates

Aspen Aerogels: Despite Recent Pressure, This Is Intriguing

Nov 17

With A 32% Price Drop For Aspen Aerogels, Inc. (NYSE:ASPN) You'll Still Get What You Pay For

Nov 07
With A 32% Price Drop For Aspen Aerogels, Inc. (NYSE:ASPN) You'll Still Get What You Pay For

Aspen Aerogels: Interesting Times

Oct 28

Aspen Aerogels (NYSE:ASPN) Is Looking To Continue Growing Its Returns On Capital

Oct 17
Aspen Aerogels (NYSE:ASPN) Is Looking To Continue Growing Its Returns On Capital

Aspen Aerogels: Current Valuation Is Not A Good Risk/Reward

Sep 26

Aspen Aerogels: Management Guidance Remains Very Conservative

Sep 18

Why Investors Shouldn't Be Surprised By Aspen Aerogels, Inc.'s (NYSE:ASPN) 32% Share Price Surge

Aug 24
Why Investors Shouldn't Be Surprised By Aspen Aerogels, Inc.'s (NYSE:ASPN) 32% Share Price Surge

Investors Shouldn't Be Too Comfortable With Aspen Aerogels' (NYSE:ASPN) Earnings

Aug 15
Investors Shouldn't Be Too Comfortable With Aspen Aerogels' (NYSE:ASPN) Earnings

Aspen Aerogels: Impressive, But Some Questions As Well

Aug 12

We Think Aspen Aerogels (NYSE:ASPN) Has A Fair Chunk Of Debt

Jul 21
We Think Aspen Aerogels (NYSE:ASPN) Has A Fair Chunk Of Debt

Aspen Aerogels: Moving Towards Profitability

Jul 12

Aspen Aerogels, Inc.'s (NYSE:ASPN) Popularity With Investors Is Clear

Jun 24
Aspen Aerogels, Inc.'s (NYSE:ASPN) Popularity With Investors Is Clear

Health Check: How Prudently Does Aspen Aerogels (NYSE:ASPN) Use Debt?

Apr 05
Health Check: How Prudently Does Aspen Aerogels (NYSE:ASPN) Use Debt?

Aspen Aerogels: Impressive And Intriguing

Mar 25

Aspen Aerogels, Inc. (NYSE:ASPN) Looks Just Right With A 53% Price Jump

Mar 08
Aspen Aerogels, Inc. (NYSE:ASPN) Looks Just Right With A 53% Price Jump

Analysts Have Made A Financial Statement On Aspen Aerogels, Inc.'s (NYSE:ASPN) Full-Year Report

Feb 15
Analysts Have Made A Financial Statement On Aspen Aerogels, Inc.'s (NYSE:ASPN) Full-Year Report

Powering Up The EV Market: Mini Deep Dive On Aspen Aerogels

Jan 08

Why Investors Shouldn't Be Surprised By Aspen Aerogels, Inc.'s (NYSE:ASPN) 40% Share Price Surge

Dec 22
Why Investors Shouldn't Be Surprised By Aspen Aerogels, Inc.'s (NYSE:ASPN) 40% Share Price Surge

Aspen Aerogels: Phoenix Rising - Assessing The Shifts, Challenges, And Potential Future Triumphs

Nov 13

Aspen Aerogels (NYSE:ASPN) Is Making Moderate Use Of Debt

Nov 03
Aspen Aerogels (NYSE:ASPN) Is Making Moderate Use Of Debt

Aspen Aerogels: Margin Expansion But Still A Lot Of Uncertainties

Sep 28

The Price Is Right For Aspen Aerogels, Inc. (NYSE:ASPN) Even After Diving 25%

Aug 12
The Price Is Right For Aspen Aerogels, Inc. (NYSE:ASPN) Even After Diving 25%

Aspen Aerogels: Not Insulating Investors From The Cold

Jun 20

Is Aspen Aerogels (NYSE:ASPN) Weighed On By Its Debt Load?

Feb 26
Is Aspen Aerogels (NYSE:ASPN) Weighed On By Its Debt Load?

Aspen Aerogels Q4 results beat estimates, co guides FY 2023 revenue in-line

Feb 15

Aspen Aerogels: No Reason To Be In A Hurry, Ample Headwinds In 2023

Jan 08

Prévisions de croissance des bénéfices et des revenus

NYSE:ASPN - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/202666475-1961128
12/31/202549939-11011510
12/31/20244508-59299
9/30/20244141-927N/A
6/30/20243571-132-21N/A
3/31/2024288-31-188-36N/A
12/31/2023239-46-218-43N/A
9/30/2023214-55-270-64N/A
6/30/2023190-71-335-94N/A
3/31/2023188-80-309-96N/A
12/31/2022180-83-272-94N/A
9/30/2022152-89-209-82N/A
6/30/2022146-68-113-51N/A
3/31/2022132-50-66-40N/A
12/31/2021122-37-32-19N/A
9/30/2021113-27-19-12N/A
6/30/2021107-26-13-7N/A
3/31/2021100-25-14-10N/A
12/31/2020100-22-13-10N/A
9/30/2020124-17-30N/A
6/30/2020135-12-5-2N/A
3/31/2020140-12-21N/A
12/31/2019139-15-3-1N/A
9/30/2019129-28-8-6N/A
6/30/2019117-32-8-4N/A
3/31/2019109-34-13-9N/A
12/31/2018104-34-12-9N/A
9/30/2018105-22-12-8N/A
6/30/2018108-19N/A-5N/A
3/31/2018112-17N/A-3N/A
12/31/2017112-19N/A-5N/A
9/30/2017103-23N/A-4N/A
6/30/2017105-23N/A-1N/A
3/31/2017108-19N/A-5N/A
12/31/2016118-12N/A-1N/A
9/30/2016127-5N/A4N/A
6/30/2016129-4N/A1N/A
3/31/2016132-5N/A9N/A
12/31/2015123-6N/A5N/A
9/30/2015113-11N/A5N/A
6/30/2015107-11N/A6N/A
3/31/2015104-50N/A2N/A
12/31/2014102-66N/A7N/A
9/30/201499-64N/A2N/A
6/30/201495-75N/A-1N/A
3/31/201491-40N/A-8N/A
12/31/2013861N/A-14N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de ASPN ( 54.4% par an) est supérieure au taux d'épargne ( 2.6% ).

Bénéfices vs marché: Les bénéfices de ASPN ( 54.4% par an) devraient croître plus rapidement que le marché US ( 15.4% par an).

Croissance élevée des bénéfices: Les bénéfices de ASPN devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de ASPN ( 22.9% par an) devrait croître plus rapidement que le marché US ( 8.9% par an).

Croissance élevée des revenus: Le chiffre d'affaires de ASPN ( 22.9% par an) devrait croître plus rapidement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de ASPN devrait être faible dans 3 ans ( 10.1 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y